Neuren Pharmaceuticals (ASX:NEU) Other Current Payables : A$2.7 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Other Current Payables?

Neuren Pharmaceuticals's Other Current Payables for the quarter that ended in Dec. 2023 was A$2.7 Mil.

Neuren Pharmaceuticals's quarterly Other Current Payables declined from Dec. 2022 (A$0.7 Mil) to Jun. 2023 (A$0.0 Mil) but then increased from Jun. 2023 (A$0.0 Mil) to Dec. 2023 (A$2.7 Mil).

Neuren Pharmaceuticals's annual Other Current Payables increased from Dec. 2021 (A$0.6 Mil) to Dec. 2022 (A$0.7 Mil) and increased from Dec. 2022 (A$0.7 Mil) to Dec. 2023 (A$2.7 Mil).

Neuren Pharmaceuticals Other Current Payables Historical Data

The historical data trend for Neuren Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Other Current Payables Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

0.22

0.59

0.56

0.72

2.74

Neuren Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial															0.56	-	0.72	-	2.74

Neuren Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Neuren Pharmaceuticals Other Current Payables Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals (ASX:NEU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

NURPF:USA

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.